Anacetrapib
- Generic Name
- Anacetrapib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H25F10NO3
- CAS Number
- 875446-37-0
- Unique Ingredient Identifier
- P7T269PR6S
- Indication
用于冠状动脉疾病（CHD）和动脉粥样硬化。
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 408
- Registration Number
- NCT00977288
Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1623
- Registration Number
- NCT00685776
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath